Treatment for Rheumatoid Arthritis in Eyes: How It Works, Results and What to Expect

Treatment for rheumatoid arthritis in eyes depends on the affected eye structure and may include preservative-free lubricants, anti-inflammatory eye medicines and treatment that controls rheumatoid arthritis throughout the body. Prompt assessment by an ophthalmologist is important because some inflammatory eye conditions can threaten vision if untreated.

Overview: treatment for rheumatoid arthritis in eyes

Treatment for rheumatoid arthritis in eyes combines treatment for the specific eye problem with control of rheumatoid arthritis (RA) throughout the body. Depending on the diagnosis, care may include preservative-free lubricating drops, anti-inflammatory eye drops, oral medicines or medicines that modify the immune system. The aim is to reduce inflammation, relieve symptoms and protect vision.

RA is an autoimmune condition that mainly affects joints, but inflammation can also involve tissues outside the joints. Eye involvement is not inevitable, and dry eye is more common than severe eye inflammation. However, a painful red eye or new vision symptoms should never be assumed to be simple dryness, especially in a person with RA.

Management is individualized. An ophthalmologist identifies the affected eye structures and monitors the response to treatment, while a rheumatologist reviews systemic disease activity and medicines. This coordinated approach is particularly important for scleritis, corneal disease and uveitis, which may need more than local eye treatment.

What happens to your eyes with rheumatoid arthritis?

Rheumatoid arthritis can affect the tear-producing glands, the surface of the eye and, less often, deeper layers of the eye. Reduced tear production or poor-quality tears can lead to dry, gritty, burning or fluctuating vision. Dry eye may occur alone or as part of Sjögren syndrome, another autoimmune condition that can coexist with RA.

Inflammation may also affect the episclera, a thin tissue layer over the white of the eye, causing episcleritis. This often produces localized redness and mild discomfort. Scleritis affects the deeper sclera and typically causes more severe, persistent pain and tenderness; it needs urgent specialist evaluation because it can damage the eye if not controlled.

Less commonly, RA is associated with peripheral ulcerative keratitis, an inflammatory condition near the edge of the cornea, or uveitis, inflammation inside the eye. These problems can cause pain, light sensitivity, redness and reduced vision. Their presence can also indicate active inflammation elsewhere in the body, so communication between eye and rheumatology teams is important.

What does rheumatoid arthritis look like in your eyes?

The appearance varies by condition. Dry eye may make the eyes look mildly red, watery or tired, even though the underlying problem is inadequate tear-film protection. The eyelids may feel sticky on waking, and vision can clear temporarily after blinking or using lubricating drops.

Episcleritis may appear as a bright-red patch or sector on the white of the eye. By contrast, scleritis can cause a deeper red, violet or bluish-red discoloration, sometimes over a larger area, together with marked pain. The eye may be tender to touch, and the redness generally does not settle quickly with ordinary over-the-counter redness-relief drops.

Corneal inflammation may not be obvious in a mirror. Symptoms such as increasing pain, light sensitivity, persistent tearing or blurred vision can be more important clues. A slit-lamp examination by an eye specialist is needed to determine the cause of redness and to check the cornea, sclera and internal eye structures safely.

How treatment works and who may need it

Treatment is directed at both symptoms and the inflammatory process. For uncomplicated dry eye, frequent lubrication and measures that support the tear film can improve comfort and protect the corneal surface. If inflammation is present on the eye surface, an ophthalmologist may prescribe anti-inflammatory treatment rather than relying on lubricants alone.

Scleritis, peripheral ulcerative keratitis and some forms of uveitis commonly require systemic treatment because inflammation may be driven by immune activity beyond the eye. A rheumatologist may adjust disease-modifying antirheumatic drugs or biologic therapies used to control RA. In selected situations, oral corticosteroids or other immune-suppressing medicines may be used under close supervision.

People with diagnosed RA who develop persistent dry eye, recurring redness, eye pain, sensitivity to light, new floaters or changes in vision are candidates for ophthalmic assessment. Those with severe pain, reduced vision or a very red eye should be assessed urgently. Treatment choice also considers medical history, current RA medicines, infection risk, eye pressure and whether the cornea is involved.

• Possible benefits: less pain and irritation, improved eye-surface health, reduced inflammation and protection of vision.
• Important limits: treatment can control inflammation but may need adjustment over time, especially if RA activity changes.

What are the best eye drops for rheumatoid arthritis?

The best eye drops for rheumatoid arthritis depend on the eye diagnosis. For dry eye, preservative-free artificial tears are commonly a suitable first option because they lubricate the surface without repeated preservative exposure. Thicker gels or ointments may be useful at night for some people, although they can temporarily blur vision.

Anti-inflammatory drops, including corticosteroid drops or other prescription treatments, may be appropriate when an ophthalmologist finds inflammation. These medications should not be started or continued without medical guidance. Steroid eye drops can raise eye pressure, contribute to cataract development and worsen certain eye infections when used inappropriately.

“Redness-relief” drops that constrict blood vessels are generally not a treatment for RA-related eye disease. They may mask redness without addressing the cause and can lead to rebound redness with frequent use. Contact lens wear may need to be reduced or paused during significant dry eye or active inflammation; an eye specialist can advise on safe use.

What to expect: assessment, treatment steps and recovery

Assessment usually begins with a discussion of eye symptoms, RA activity and current medicines. The ophthalmologist checks visual acuity, eye pressure and the front of the eye with a slit lamp. Tear-film testing, staining of the cornea and, when needed, examination of the retina may help distinguish dry eye from episcleritis, scleritis, infection or another cause of eye symptoms.

Once a diagnosis is made, treatment usually follows a stepwise plan. Dry eye care may start with lubricants, environmental adjustments and treatment for eyelid or tear-gland problems. More active inflammation may require prescription drops and closer follow-up. For serious inflammation, the eye specialist and rheumatologist coordinate systemic medication decisions and monitor for treatment effects.

Recovery timelines vary. Lubricating treatment may ease dryness within days, though stable control often takes weeks and regular use. Episcleritis may settle over days to a few weeks. Scleritis and corneal inflammation can require weeks to months of treatment and careful monitoring. Follow-up visits are essential even when symptoms improve, because inflammation can persist or recur.

Potential treatment risks depend on the medicine used and may include irritation from drops, raised eye pressure with corticosteroids, infection risk with immune-suppressing medicines and medicine-specific effects elsewhere in the body. Patients should report worsening redness, pain, discharge, light sensitivity or vision changes promptly rather than stopping prescribed systemic medicines on their own.

Prevention, self-care and long-term outlook

Not every RA-related eye problem can be prevented, but good control of rheumatoid arthritis and regular medical follow-up may reduce inflammatory complications. Taking prescribed RA medicines as directed and discussing new symptoms early helps the care team respond before eye inflammation becomes more severe.

For dry eye, practical measures include using preservative-free lubricants as advised, taking regular screen breaks, blinking fully, avoiding smoke and direct air flow, and considering a humidified environment. Warm compresses and eyelid hygiene may help when eyelid-gland dysfunction contributes to symptoms, but they should be gentle and stopped if they increase irritation.

Smoking cessation is beneficial for overall health and is especially relevant in RA because smoking can worsen disease activity and treatment response. A balanced diet, sleep, movement appropriate to joint health and regular rheumatology care support general wellbeing, although they do not replace prescribed treatment for eye inflammation.

Acibadem International’s multidisciplinary ophthalmology and rheumatology specialists, working in JCI-accredited hospitals, can assess RA-related eye symptoms and coordinate care for international patients when needed.

When to seek medical care

Anyone with rheumatoid arthritis should arrange a non-urgent eye assessment for persistent dryness, recurrent redness, irritation or fluctuating vision. These symptoms are often manageable, but an examination can identify whether dry eye, eyelid disease or inflammation is responsible and guide appropriate treatment.

Urgent same-day assessment is appropriate for severe or deep eye pain, marked redness, light sensitivity, sudden blurred or reduced vision, a new blind spot, new flashes or many floaters, or a contact-lens-related painful red eye. These symptoms may have causes unrelated to RA as well, including infection, and should not be treated with leftover eye drops.

Regular eye reviews may be recommended for people using long-term corticosteroids or medicines that require eye monitoring. The ophthalmologist and rheumatologist can decide on an appropriate schedule based on the person’s symptoms, eye findings and overall RA treatment plan.

What is the average life expectancy for someone with rheumatoid arthritis?

There is no single average life expectancy that applies to every person with rheumatoid arthritis. Outcomes vary with age at diagnosis, disease severity, smoking, heart and lung health, infection risk, access to care and how well inflammation is controlled. Modern RA treatment has improved disease control substantially for many people.

RA is associated with a higher risk of some health problems, particularly cardiovascular disease and certain infections, which can affect long-term health. This is why routine preventive care, vaccination discussions, smoking cessation, management of blood pressure and cholesterol, and regular rheumatology follow-up are important.

Eye involvement does not by itself determine life expectancy. It does, however, deserve prompt assessment because it may signal active systemic inflammation and because early treatment can help preserve vision and comfort.

Frequently asked questions

Can rheumatoid arthritis cause blindness?

Most people with RA-related eye symptoms do not lose vision, especially when dry eye and inflammation are recognized early. However, severe scleritis, corneal ulceration or untreated intraocular inflammation can threaten sight. Pain, light sensitivity or reduced vision should be assessed urgently by an ophthalmologist.

Can artificial tears treat rheumatoid arthritis eye inflammation?

Artificial tears can relieve dryness and protect the eye surface, but they do not treat deeper inflammation such as scleritis or uveitis. They are often one part of a broader plan for dry eye. An eye specialist can determine whether prescription treatment is needed.

Why are my eyes dry when I have rheumatoid arthritis?

RA can affect the immune system’s activity in tear-producing glands and on the eye surface, reducing tear quality or quantity. Some people with RA also have Sjögren syndrome, which commonly causes dry eyes and dry mouth. Medicines, screen use, contact lenses and dry environments can add to symptoms.

Is a red eye always caused by rheumatoid arthritis?

No. Redness can result from allergies, infection, dry eye, a scratched cornea, contact lens complications and many other conditions. Because RA can also cause significant inflammation, a painful or persistent red eye should be examined rather than self-treated.

Will treating rheumatoid arthritis improve eye symptoms?

Controlling systemic RA can be an important part of treating inflammatory eye disease, particularly scleritis and corneal inflammation. Dry eye may still need direct eye-surface treatment even when joint symptoms are well controlled. The best plan is usually coordinated by ophthalmology and rheumatology clinicians.

Should people with rheumatoid arthritis have regular eye examinations?

A routine eye examination is sensible, particularly for people with dry-eye symptoms, previous eye inflammation or medicines that need eye monitoring. The frequency depends on symptoms, treatment and individual risk factors. New pain, light sensitivity or vision changes should be assessed sooner than a routine appointment.

References

• American College of Rheumatology
• American Academy of Ophthalmology
• National Eye Institute
• Arthritis Foundation
• Mayo Clinic

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.